NCT04840056 Prediction of Gastric Cancer in Intestinal Metaplasia and Atrophic Gastritis
| NCT ID | NCT04840056 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chinese University of Hong Kong |
| Condition | Gastric Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,300 participants |
| Start Date | 2021-04-15 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,300 participants in total. It began in 2021-04-15 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objectives of this study are: * To identify clinical or histological factors associated with gastric cancer development in patients with IM and AG * To establish a machine learning algorithm for prediction of future gastric cancer risks and individual risk stratification in patient with IM and AG
Eligibility Criteria
Inclusion Criteria: * Adults \>= 18 years of age * Histologically proven atrophic gastritis or intestinal metaplasia (at antrum and/or body and/or angular of stomach) Exclusion Criteria: \- none
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04840056 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Gastric Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04840056 currently recruiting?
Yes, NCT04840056 is actively recruiting participants. Contact the research team at felix.sia@cuhk.edu.hk for enrollment information.
Where is the NCT04840056 trial being conducted?
This trial is being conducted at Shatin, Hong Kong.
Who is sponsoring the NCT04840056 clinical trial?
NCT04840056 is sponsored by Chinese University of Hong Kong. The trial plans to enroll 1,300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.